vs

Side-by-side financial comparison of California BanCorp \ CA (BCAL) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $45.9M, roughly 1.7× California BanCorp \ CA). California BanCorp \ CA runs the higher net margin — 35.8% vs 7.4%, a 28.4% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 0.8%). California BanCorp \ CA produced more free cash flow last quarter ($56.9M vs $9.7M). Over the past eight quarters, California BanCorp \ CA's revenue compounded faster (44.7% CAGR vs 22.7%).

Pacific Premier Bancorp, Inc. is an American bank holding company under the Bank Holding Company Act of 1956 headquartered in Irvine, California, US. Its principal business focuses on Pacific Premier Bank, which offers a range of financial services to individuals, businesses, and professionals. The bank operates numerous branches in California, Arizona, Nevada, and Washington.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

BCAL vs VMD — Head-to-Head

Bigger by revenue
VMD
VMD
1.7× larger
VMD
$76.2M
$45.9M
BCAL
Growing faster (revenue YoY)
VMD
VMD
+24.7% gap
VMD
25.5%
0.8%
BCAL
Higher net margin
BCAL
BCAL
28.4% more per $
BCAL
35.8%
7.4%
VMD
More free cash flow
BCAL
BCAL
$47.2M more FCF
BCAL
$56.9M
$9.7M
VMD
Faster 2-yr revenue CAGR
BCAL
BCAL
Annualised
BCAL
44.7%
22.7%
VMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BCAL
BCAL
VMD
VMD
Revenue
$45.9M
$76.2M
Net Profit
$16.4M
$5.6M
Gross Margin
57.9%
Operating Margin
48.8%
11.0%
Net Margin
35.8%
7.4%
Revenue YoY
0.8%
25.5%
Net Profit YoY
-2.1%
30.7%
EPS (diluted)
$0.50
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCAL
BCAL
VMD
VMD
Q4 25
$45.9M
$76.2M
Q3 25
$45.2M
$71.9M
Q2 25
$44.3M
$63.1M
Q1 25
$44.8M
$59.1M
Q4 24
$45.5M
$60.7M
Q3 24
$38.1M
$58.0M
Q2 24
$22.2M
$55.0M
Q1 24
$21.9M
$50.6M
Net Profit
BCAL
BCAL
VMD
VMD
Q4 25
$16.4M
$5.6M
Q3 25
$15.7M
$3.5M
Q2 25
$14.1M
$3.2M
Q1 25
$16.9M
$2.6M
Q4 24
$16.8M
$4.3M
Q3 24
$-16.5M
$3.9M
Q2 24
$190.0K
$1.5M
Q1 24
$4.9M
$1.6M
Gross Margin
BCAL
BCAL
VMD
VMD
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Q1 24
58.9%
Operating Margin
BCAL
BCAL
VMD
VMD
Q4 25
48.8%
11.0%
Q3 25
48.3%
7.8%
Q2 25
45.3%
8.1%
Q1 25
52.8%
6.5%
Q4 24
52.2%
10.6%
Q3 24
-59.1%
9.7%
Q2 24
1.3%
6.6%
Q1 24
33.1%
4.4%
Net Margin
BCAL
BCAL
VMD
VMD
Q4 25
35.8%
7.4%
Q3 25
34.7%
4.9%
Q2 25
31.8%
5.0%
Q1 25
37.6%
4.4%
Q4 24
37.7%
7.1%
Q3 24
-43.2%
6.7%
Q2 24
0.9%
2.7%
Q1 24
22.5%
3.2%
EPS (diluted)
BCAL
BCAL
VMD
VMD
Q4 25
$0.50
$0.14
Q3 25
$0.48
$0.09
Q2 25
$0.43
$0.08
Q1 25
$0.52
$0.06
Q4 24
$0.54
$0.10
Q3 24
$-0.59
$0.10
Q2 24
$0.01
$0.04
Q1 24
$0.26
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCAL
BCAL
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$399.9M
$13.5M
Total DebtLower is stronger
$33.8M
Stockholders' EquityBook value
$576.6M
$141.5M
Total Assets
$4.0B
$199.2M
Debt / EquityLower = less leverage
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCAL
BCAL
VMD
VMD
Q4 25
$399.9M
$13.5M
Q3 25
$559.2M
$11.1M
Q2 25
$430.1M
$20.0M
Q1 25
$439.2M
$10.2M
Q4 24
$388.2M
$17.5M
Q3 24
$614.4M
$11.3M
Q2 24
$104.7M
$8.8M
Q1 24
$86.5M
$7.3M
Total Debt
BCAL
BCAL
VMD
VMD
Q4 25
$33.8M
Q3 25
$33.4M
Q2 25
$52.9M
Q1 25
$70.3M
Q4 24
$69.7M
Q3 24
$69.1M
Q2 24
$42.9M
Q1 24
$44.9M
Stockholders' Equity
BCAL
BCAL
VMD
VMD
Q4 25
$576.6M
$141.5M
Q3 25
$564.7M
$133.6M
Q2 25
$547.6M
$139.7M
Q1 25
$531.4M
$134.8M
Q4 24
$511.8M
$131.4M
Q3 24
$498.1M
$125.0M
Q2 24
$293.2M
$119.4M
Q1 24
$292.5M
$116.3M
Total Assets
BCAL
BCAL
VMD
VMD
Q4 25
$4.0B
$199.2M
Q3 25
$4.1B
$202.4M
Q2 25
$4.0B
$184.6M
Q1 25
$4.0B
$178.1M
Q4 24
$4.0B
$177.1M
Q3 24
$4.4B
$169.5M
Q2 24
$2.3B
$163.9M
Q1 24
$2.3B
$154.9M
Debt / Equity
BCAL
BCAL
VMD
VMD
Q4 25
0.06×
Q3 25
0.06×
Q2 25
0.10×
Q1 25
0.13×
Q4 24
0.14×
Q3 24
0.14×
Q2 24
0.15×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCAL
BCAL
VMD
VMD
Operating Cash FlowLast quarter
$57.3M
$18.4M
Free Cash FlowOCF − Capex
$56.9M
$9.7M
FCF MarginFCF / Revenue
124.1%
12.7%
Capex IntensityCapex / Revenue
0.8%
11.5%
Cash ConversionOCF / Net Profit
3.49×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$93.1M
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCAL
BCAL
VMD
VMD
Q4 25
$57.3M
$18.4M
Q3 25
$16.0M
$18.4M
Q2 25
$13.4M
$12.3M
Q1 25
$7.0M
$2.9M
Q4 24
$50.3M
$15.0M
Q3 24
$18.3M
$12.7M
Q2 24
$309.0K
$10.2M
Q1 24
$8.1M
$1.2M
Free Cash Flow
BCAL
BCAL
VMD
VMD
Q4 25
$56.9M
$9.7M
Q3 25
$15.9M
$10.7M
Q2 25
$13.4M
$4.1M
Q1 25
$6.9M
$-12.6M
Q4 24
$49.7M
$3.2M
Q3 24
$18.1M
$1.7M
Q2 24
$171.0K
$1.2M
Q1 24
$8.0M
$-4.8M
FCF Margin
BCAL
BCAL
VMD
VMD
Q4 25
124.1%
12.7%
Q3 25
35.1%
14.9%
Q2 25
30.2%
6.5%
Q1 25
15.3%
-21.4%
Q4 24
109.2%
5.2%
Q3 24
47.5%
3.0%
Q2 24
0.8%
2.3%
Q1 24
36.4%
-9.5%
Capex Intensity
BCAL
BCAL
VMD
VMD
Q4 25
0.8%
11.5%
Q3 25
0.2%
10.6%
Q2 25
0.1%
12.9%
Q1 25
0.2%
26.2%
Q4 24
1.2%
19.5%
Q3 24
0.5%
19.0%
Q2 24
0.6%
16.3%
Q1 24
0.4%
11.9%
Cash Conversion
BCAL
BCAL
VMD
VMD
Q4 25
3.49×
3.27×
Q3 25
1.02×
5.23×
Q2 25
0.95×
3.88×
Q1 25
0.41×
1.09×
Q4 24
3.00×
3.47×
Q3 24
3.29×
Q2 24
1.63×
6.94×
Q1 24
1.63×
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons